STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. XGN
  4. [EFFECT] Exagen Inc. SEC Filing

[EFFECT] Exagen Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 4:01 P.M.
Form: S-3
CIK: 0001274737
Company Name: EXAGEN INC.
File Number: 333-288199

Source: View Original Filing on SEC EDGAR

Stock XGN logo
Exagen Inc.

NASDAQ:XGN

XGN Rankings

#4549 Ranked by Market Cap
N/A Ranked by Dividends

XGN Latest News

Nov 11, 2025
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Nov 4, 2025
Exagen Inc. Reports Strong Q3 2025 Results
Oct 23, 2025
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
Oct 21, 2025
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
Aug 6, 2025
Exagen Inc. to Participate in Third Quarter Investor Conferences

XGN Latest SEC Filings

Nov 4, 2025
[10-Q] EXAGEN INC. Quarterly Earnings Report
Nov 4, 2025
[8-K] EXAGEN INC. Reports Material Event
Oct 20, 2025
[Form 4] EXAGEN INC. Insider Trading Activity
Sep 4, 2025
[Form 4] Exagen Inc. Insider Trading Activity
Aug 14, 2025
[SCHEDULE 13G/A] Exagen Inc. SEC Filing

XGN Stock Data

169.75M
15.85M
15.29%
57.82%
2.99%
Diagnostics & Research
Services-medical Laboratories
Link
United States
VISTA